The disease can be divided into four major molecular subtypes: luminal A BC, luminal B BC, human epidermal growth factor receptor 2 (HER2)-overexpression BC and triple-negative BC (TNBC) [2]. This evidence concerns the gene ERBB2 and breast cancer.